Indefinite Delivery Contract SPE2DR25D7904

The federal contract IDV award SPE2DR25D7904 is a single-award Indefinite Delivery Contract held by Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract, valued at $9,999,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to provide worldwide pharmaceutical and medical supply support to various Department of Defense (DoD) customers, including the Defense Health Agency, DoD components, the U.S. Coast Guard, and U.S. Naval Fleet. The contract has a base period of 30 months and three 30-month option periods, for a total potential duration through December 2036.

The scope of the contract encompasses a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This IDC serves as a primary vehicle for DLA to efficiently procure essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract was awarded through an unrestricted, fully competitive acquisition process with a Lowest Price Technically Acceptable (LPTA) evaluation approach, without any set-aside designations.